The identificationof a new structural class of HV1 inhibitors contributesto our understanding of the structural requirements for inhibitionof this ion channel and opens up the possibility of investigatingthe role of HV1 inhibitors in various pathological conditionsand in cancer therapy. The gene discussed is HVCN1; the disease is cancer.